Surging global incidence of complex soft tissue and bone sarcomas, expanding clinical demand for personalized targeted systemic therapies, and continuous molecular oncology innovations in immunotherapy combinations are driving rapid growth across the global Sarcoma Drugs Market. Sarcoma drugs—comprising multi-kinase inhibitors (such as pazopanib), anthracycline-based chemotherapy...
